const data = [
  {
    text: "",
    id: 1,
    description:
      "Insufficient or flawed preclinical testing may fail to identify potential safety concerns or efficacy issues in a compound. This can lead to expensive late-stage failures.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 2,
    description:
      "When a drug compound lacks specificity for its intended target, it may affect other biological pathways, causing unexpected side effects or ineffectiveness.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 3,
    description:
      "Compounds may exhibit unexpected toxic effects, either due to inherent toxicity or accumulation of toxic metabolites, resulting in safety concerns and clinical trial setbacks.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 4,
    description:
      "Poorly optimized drug formulations can lead to issues with stability, bioavailability, or patient compliance, ultimately causing compound failure.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 5,
    description: "A compound's PK/PD profile may not align with the desired therapeutic effect, leading to inadequate dosing or a lack of efficacy.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 6,
    description: "Bacterial or viral resistance can develop when using antibiotics or antivirals, rendering the compound ineffective over time.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 7,
    description:
      "Inconsistent or poor-quality manufacturing processes can result in variations in drug quality, which can lead to regulatory issues or compromised effectiveness.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 8,
    description:
      "Poorly designed clinical trials, including inappropriate patient populations, endpoints, or dosing regimens, can fail to demonstrate a compound's true potential.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 9,
    description:
      "Failure to meet regulatory standards and requirements, such as Good Manufacturing Practices (GMP) or Good Clinical Practices (GCP), can result in delays, rejections, or recalls.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 10,
    description:
      "Intense competition from existing drugs or the emergence of more effective alternatives can render a compound economically unviable.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 11,
    description:
      "Intense competition from existing drugs or the emergence of more effective alternatives can render a compound economically unviable.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 12,
    description:
      "Occasionally, compounds may cause rare and severe adverse events in a small subset of patients, leading to safety concerns and market withdrawal.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 13,
    description:
      "Delays, budget overruns, or a lack of coordination in the research and development process can result in compound failure due to resource depletion or changing market conditions.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 14,
    description:
      "If patients do not adhere to prescribed dosing regimens or treatment plans, it can impact a compound's effectiveness and overall success in the market.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  },
  {
    text: "",
    id: 15,
    description: "Difficulties in gaining market access or securing favorable reimbursement policies can hinder a compound's commercial success.",
    references: [
      "https://www.pfizer.com/",
      "https://www.figma.com/file/mMYg7x3FESNrRNRYUdinOl/Pfizer-GenAI?type=design&node-id=1643-2945&mode=design&t=5gUO8AScWs9Mj29l-0"
    ] // List of references
  }
];

export { data };
